ARTICLE | Clinical News
DTaP vaccine for infants: Started Phase II/III safety and immunogenicity testing in 3,000 infants
September 20, 1993 7:00 AM UTC
North American Vaccine (NVX) Product: DTaP vaccine for infants Indication: Prevent DTaP (diphtheria, tetanus, and acellular pertussis) Status: Started Phase II/III safety and immunogenicity testing i...